Loo CK, Mitchell PB 2005. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy

School of Psychiatry, University of NSW, Psychiatrist, Black Dog Institute and South Eastern Sydney Illawarra Area Health Service, Australia.
Journal of Affective Disorders (Impact Factor: 3.71). 12/2005; 88(3):255-67. DOI: 10.1016/j.jad.2005.08.001
Source: PubMed

ABSTRACT There is a growing interest in extending the use of repetitive transcranial magnetic stimulation (rTMS) beyond research centres to the widespread clinical treatment of depression. Thus it is timely to critically review the evidence for the efficacy of rTMS as an antidepressant treatment. Factors relevant to the efficacy of rTMS are discussed along with the implications of these for the further optimization of rTMS.
Clinical trials of the efficacy of rTMS in depressed subjects are summarized and reviewed, focusing mainly on sham-controlled studies and meta-analyses published to date.
There is a fairly consistent statistical evidence for the superiority of rTMS over a sham control, though the degree of clinical improvement is not large. However, this data is derived mainly from two-week comparisons of rTMS versus sham, and evidence suggests greater efficacy with longer treatment courses. Studies so far have also varied greatly in approaches to rTMS stimulation (with respect to stimulation site, stimulus parameters etc) with little empirical evidence to inform on the relative merits of these approaches.
Only studies published in English were reviewed. Many of the studies in the literature had small sample sizes and different methodologies, making comparisons between studies difficult.
Current published studies and meta-analyses have evaluated the efficacy of rTMS as given in treatment paradigms that are almost certainly suboptimal (e.g of two weeks' duration). While the data nevertheless supports positive outcomes for rTMS, there is much scope for the further refinement and development of rTMS as an antidepressant treatment. Ongoing research is critical for optimizing the efficacy of rTMS.

Download full-text


Available from: Philip Bowden Mitchell, Aug 28, 2015
1 Follower
  • Source
    • "Numerous studies on the efficacy of rTMS revealed that rTMS is an effective treatment option in major depressive disorder. In most meta-analyses, rTMS is superior to sham control (Burt, Lisanby, and Sackeim, 2002; Holtzheimer, Russo, and Avery, 2001; Kozel and George, 2002; Lam, Chan, Wilkins- Ho, and Yatham, 2008; Loo and Mitchell, 2005; McNamara, Ray, Arthurs, and Boniface, 2001; Schutter, 2009). In one exception, however, Couturier (2005) reported in his metaanalysis in 2005 that there were no significant differences between rTMS and sham control (Couturier, 2005). "
    [Show description] [Hide description]
    DESCRIPTION: Transcranial magnetic stimulation (TMS) was introduced as a novel method of brain stimulation in 1985, and now it is widely used in research of cortical excitability, neuronal connectivity and plasticity, and also is applied to the treatment of various neurological and psychiatric conditions. This review is written with the purpose of introducing the brief conspectus and area of therapeutic application of TMS. The techniques, equipment and treatment modalities of TMS are continuously developing, and its area of therapeutic application is being extended. For determining the form of the optimal therapeutic application of TMS in various clinical conditions, more data from controlled studies should be obtained.
  • Source
    • "There were 20–30 s between the train intervals used. Decision to select 90% of the MT was based on the prior publications where rTMS was used for the stimulation of DLPFC in various neuro- and psychiatric disorders (reviewed in Pascual-Leone et al., 2000; Wassermann and Lisanby, 2001; Daskalakis et al., 2002; Gershon et al., 2003; Loo and Mitchell, 2005; Greenberg, 2007; Oberman et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Reports in autism spectrum disorders (ASD) of a minicolumnopathy with consequent deficits of lateral inhibition help explain observed behavioral and executive dysfunctions. We propose that neuromodulation based on rTMS will enhance lateral inhibition through activation of inhibitory double bouquet interneurons and will be accompanied by improvements in the prefrontal executive functions. Methods: The current study used ERPs in a visual oddball task with illusory figures. We compared clinical, behavioral and electrocortical outcomes in 2 groups of children with autism (TMS, wait-list group [WTL]). We predicted that 18 session long course in autistic patients will have better behavioral and ERP outcomes as compared to age- and IQ-matched wait-list group. We used 18 sessions of 1Hz rTMS applied over the dorso-lateral prefrontal cortex in 27 individuals with ASD diagnosis. The WTL group was comprised of 27 age-matched ASD subjects. Results: Post-TMS evaluations showed decreased irritability and hyperactivity and decreased stereotypic behaviors. Following rTMS we found decreased amplitude and prolonged latency in the fronto-central ERPs to non-targets in the TMS group. These ERP changes along with increased centro-parietal ERPs to targets are indicative of more efficient processing of information post-TMS. Another finding was increased magnitude of error-related negativity (ERN) during commission errors. We calculated normative post-error reaction time (RT) slowing response in both groups and found that rTMS was accompanied by post-error RT slowing and higher accuracy of responses, whereas the WTL group kept on showing typical for ASD post-error RT speeding and had higher error rate. Conclusion: Results from our study indicate that rTMS improves executive functioning in ASD as evidenced by normalization of ERP responses and behavioral reactions during executive function test, and also by improvements in clinical behavioral evaluations.
    Frontiers in Systems Neuroscience 08/2014; 8:134. DOI:10.3389/fnsys.2014.00134
  • Source
    • "duration of two weeks). The data support positive outcomes for rTMS, but not large clinical effects [18]. However, a few studies suggest that a longer course of rTMS is necessary for optimal therapeutic outcomes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transcranial magnetic stimulation (TMS) is a noninvasive and safe technique for motor cortex stimulation. TMS is used to treat neurological and psychiatric disorders, including mood and movement disorders. TMS can also treat several types of chronic neuropathic pain. The pain relief mechanism of cortical stimulation is caused by modifications in neuronal excitability. Depression is a common co-morbidity with chronic pain. Pain and depression should be treated concurrently to achieve a positive outcome. Insomnia also frequently occurs with chronic lower back pain. Several studies have proposed hypotheses for TMS pain management. Herein, we report two cases with positive results for the treatment of depression and insomnia with chronic low back pain by TMS.
    The Korean journal of pain 07/2014; 27(3):285-9. DOI:10.3344/kjp.2014.27.3.285
Show more